Emerald Advisers, LLC 908 Devices Inc. Transaction History

Emerald Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$7.0 - $17.96 $560,805 - $1.44 Million	80,115 Added 875.38%	89,267 $680,000
Q3 2022 Oct 25, 2022	SELL	$15.18 - $24.99 $4.73 Million - $7.78 Million	-311,290 Reduced 97.14%	9,152 $151,000
Q2 2022 Jul 29, 2022	SELL	$13.3 - $20.74 $119,700 - $186,660	-9,000 Reduced 2.73%	320,442 $6.6 Million
Q1 2022 Apr 29, 2022	BUY	$13.18 - $26.28 $377,185 - $752,081	28,618 Added 9.51%	329,442 $6.26 Million
Q4 2021 Feb 02, 2022	BUY	$23.17 - $38.77 $3.89 Million - $6.52 Million	168,055 Added 126.58%	300,824 $7.78 Million
Q3 2021 Oct 28, 2021	BUY	$29.99 - $39.13 $3.98 Million - $5.2 Million	132,769 New	132,769 $4.32 Million
Q1 2021 Apr 29, 2021	SELL	$39.94 - $75.0 $645,310 - $1.21 Million	-16,157 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$49.0 - $67.92 $791,693 - $1.1 Million	16,157 New	16,157 $920,000

18.4M

14.1K

22K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $61.3M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.